Assessment of Comfort during Less Invasive Surfactant Administration in Very Preterm Infants: A Multicenter Study
Neonatology · 2023
DOI: 10.1159/000530333 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neonatology, 2023. Verfasst von Karin Pichler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics, Comprehensive Center for Pediatrics, Medical Univers…. Hauptthemen laut MEDLINE: Pulmonary Surfactants, Infant, Premature, Diseases, Respiratory Distress Syndrome, Newborn. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Neonatologie
Abstract (Originalsprache)
Introduction
This study was set up to investigate if and to what extent non-pharmacological analgesia is able to provide comfort to very preterm infants (VPI) during less invasive surfactant administration (LISA).
Methods
This was a prospective non-randomized multicenter observational study performed in level IV NICUs. Inborn VPI with a gestational age between 220/7 and 316/7 weeks, signs of respiratory distress syndrome, and the need for surfactant replacement were included. Non-pharmacological analgesia was performed in all infants during LISA. In case of failure of the first LISA attempt, additional analgosedation could be administered. COMFORTneo scores during LISA were assessed.
Results
113 VPI with a mean gestational age of 27 weeks (+/− 2.3 weeks) and mean birth weight of 946 g (+/− 33 g) were included. LISA was successful at the first laryngoscopy attempt in 81%. COMFORTneo scores were highest during laryngoscopy. At this time point, non-pharmacological analgesia provided adequate comfort in 61% of the infants. 74.4% of lower gestational aged infants (i.e., 220–266 weeks) were within the comfort zone during laryngoscopy compared to 51.6% of higher gestational aged infants (i.e., 270–320 weeks) (p = 0.016). The time point of surfactant administration did not influence the COMFORTneo scores during the LISA procedure.
Conclusion
Non-pharmacological analgesia provided comfort in as much as 61% of the included VPI during LISA. Further research is needed to both develop strategies to identify infants who, despite receiving non-pharmacological analgesia, are at high risk for experiencing discomfort during LISA and define patient-tailored dosage and choice of analgosedative drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria, karin.a.pichler@meduniwien.ac.at.
- Division of Neonatology, Department of Paediatrics, University of Cologne, Cologne, Germany.
- Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Zitieren
APA
Pichler, K., Kuehne, B., Dekker, J., Stummer, S., Giordano, V., Berger, A., Kribs, A., & Klebermass-Schrehof, K. (2023). Assessment of Comfort during Less Invasive Surfactant Administration in Very Preterm Infants: A Multicenter Study. Neonatology. https://doi.org/10.1159/000530333
Vancouver
Pichler K, Kuehne B, Dekker J, Stummer S, Giordano V, Berger A, et al. Assessment of Comfort during Less Invasive Surfactant Administration in Very Preterm Infants: A Multicenter Study. Neonatology. 2023. doi:10.1159/000530333
BibTeX
@article{Pichler2023,
author = {Pichler, Karin and Kuehne, Benjamin and Dekker, Janneke and Stummer, Sophie and Giordano, Vito and Berger, Angelika and Kribs, Angela and Klebermass-Schrehof, Katrin},
title = {Assessment of Comfort during Less Invasive Surfactant Administration in Very Preterm Infants: A Multicenter Study},
journal = {Neonatology},
year = {2023},
doi = {10.1159/000530333}
}
EUVIMED